etoposide 20mg/ml concentrate for solution for infusion (1000mg/50ml vial)
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion
actavis group ptc ehf - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
etoposide injection usp solution
sandoz canada incorporated - etoposide - solution - 20mg - etoposide 20mg - antineoplastic agents
etoposide (rex)
rex medical ltd - etoposide 20 mg/ml - solution for injection - 20 mg/ml - active: etoposide 20 mg/ml excipient: benzyl alcohol citric acid ethanol macrogol 300 polysorbate 80 - small-cell lung cancer: etoposide solution for injection is indicated for the first-line treatment of small cell lung cancer with additional chemotherapeutic agents.
etoposide-teva 20 mg/ml concentrate for solution for infusion
teva pharma b.v. - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
etoposide injection
thymoorgan gmbh pharmazir & co. k.g - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml
etoposide 20mg/ml concentrate for solution for infusion
accord healthcare ireland ltd. - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
etoposide injection
hikma pharmaceuticals usa inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide injection, usp is indicated in the management of the following neoplasms: etoposide injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.
etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide
etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide